| abstract |
Provided by the present invention are placental perfusate, placental perfusate cells, placenta-derived intermediate natural killer cells, natural killer cells derived from a combination of placenta and umbilical cord blood, and combinations thereof. Also provided by the present invention are compositions comprising placental perfusate, placental perfusate cells, placenta-derived intermediate natural killer cells and combined natural killer cells and combinations thereof, and use them to inhibit tumor cells, cancer cells, etc. Methods of growing or proliferating and methods of treating individuals having tumor cells. Also provided herein are use of placental perfusate, placental perfusate-derived cells, natural killer cells derived from placenta (eg, from placental perfusate) and/or comprising placental perfusate (eg, from placental perfusate) A method of natural killer cells in combination with umbilical cord blood natural killer cells for the treatment of an individual suffering from a tumor or graft-versus-host disease. |